Skip to main navigation
Careers
Contact
Search
About
Overview
Leadership
Board
Science
Pipeline
Overview
IL-17
Integrin Programs
Investors
Overview
News Releases
Events and Presentations
Events
Presentations
Corporate Governance
Governance Overview
Committee Composition
Financial Information
SEC Filings
Stock Information
Stock Quote & Chart
Shareholder Services
Investor FAQs
Email Alerts
RSS Feeds
Investors
News Releases
Year
None
2021
Sep 14, 2021
DICE Therapeutics Announces Pricing of Upsized Initial Public Offering
